This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Steven J. Huber, PhD; John T. Kissel, MD
Columbus, Ohio

Arch Neurol. 1990;47(3):254.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We have read with interest the comments of Brumback regarding the influence of tricyclics on behavioral features of myotonic dystrophy. In fact, due to their possible influence on cognitive and depressive features of the disease, none of the patients who were in our study had been taking antidepressants for at least 6 months prior to the time of examination. The exact role of tricyclics in the treatment of myotonic dystrophy is at present uncertain due to the lack of doubleblind studies, but the preliminary data provided by Brumback and associates certainly suggest that such studies may be worthwhile. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?